Companion Medical started selling its smart insulin pen in the U.S. today, according to the San Diego, Calif.-based company.
The InPen system, which combines an insulin injector pen and a smartphone app, is compatible with Eli Lilly‘s (NYSE:LLY) Humalog and Novo Nordisk‘s (NYSE:NVO) Novolog fast-acting insulin.
Get the full story at our sister site, Drug Delivery Business News.
The post Companion Medical launches smart insulin pen in U.S. appeared first on MassDevice.